HLA-DRB1 and myeloid sarcoma: New research has linked DNA hypomethylation within exon 2 of the MHC class II DRB1*1501 MS risk allele, abundant transcripts of this allele in monocytes, B cells, CD4+ T cells, and CD8+ T cells, and MS disease status [29,30].